Product Information
NIZATIDINE 150 MG CAPSULE is a generic product labeled by Epic Pharma LLC, priced at $0.8042 per EA under NDC 42806029960. Its NADAC has been published 73 times since May 14, 2025.
FDA first approved this application on Jul 5, 2002. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
150 mg/1
Manufacturer
Epic Pharma LLCNDC
42806029960
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
NIZATIDINEApproval Type
Generic (ANDA)
FDA Application
ANDA076178FDA Approved
7/5/2002
TE Code
AB
On Market Since
10/25/2024
Pharmacological Classes
Price Statistics
The NADAC for NIZATIDINE 150 MG CAPSULE has been published 73 times since May 14, 2025, and over the history we have for it it has declined 9.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8042 per EA |
|---|---|
| All-time high | $0.8918 (May 14, 2025) |
| All-time low | $0.7544 (Nov 19, 2025) |
| 52-week high | $0.8707 |
| 52-week low | $0.7544 |
| Median price | $0.8259 |
| Average price | $0.8233 |
| Largest weekly change | +6.3% (Jan 21, 2026) |
| Weeks tracked | 73 |
| Tracking since | May 14, 2025 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 71% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Epic Pharma LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Nizatidine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-2 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NIZATIDINE 150 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for NIZATIDINE 150 MG CAPSULE, manufactured by Epic Pharma LLC, is $0.8042 per EA (NDC 42806029960), effective Sep 30, 2026.
How has the price of NIZATIDINE 150 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for NIZATIDINE 150 MG CAPSULE has declined 9.8%. It has been tracked across 73 weekly CMS publications since May 14, 2025.
What are the highest and lowest recorded NADAC prices for NIZATIDINE 150 MG CAPSULE?
Since May 14, 2025, the NADAC for NIZATIDINE 150 MG CAPSULE has ranged from a low of $0.7544 (Nov 19, 2025) to a high of $0.8918 (May 14, 2025), with a median of $0.8259 per EA.
Are there cheaper alternatives to NIZATIDINE 150 MG CAPSULE?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NIZATIDINE 150 MG CAPSULE, is $0.2352 per EA — about 71% below NIZATIDINE 150 MG CAPSULE.
Who manufactures NIZATIDINE 150 MG CAPSULE?
NIZATIDINE 150 MG CAPSULE (NDC 42806029960) is labeled by Epic Pharma LLC, and CMS classifies it as a generic product.